These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33206204)

  • 21. The use of induced pluripotent stem cells in domestic animals: a narrative review.
    Scarfone RA; Pena SM; Russell KA; Betts DH; Koch TG
    BMC Vet Res; 2020 Dec; 16(1):477. PubMed ID: 33292200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications.
    Liu G; David BT; Trawczynski M; Fessler RG
    Stem Cell Rev Rep; 2020 Feb; 16(1):3-32. PubMed ID: 31760627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of pluripotent stem cells for treatment of human neuroendocrine disorders.
    Suga H
    Cell Tissue Res; 2019 Jan; 375(1):267-278. PubMed ID: 30078102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional Pituitary Tissue Generation from Human Embryonic Stem Cells.
    Kano M; Suga H; Kasai T; Ozone C; Arima H
    Curr Protoc Neurosci; 2018 Apr; 83(1):e48. PubMed ID: 30040229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vitro Differentiation of Pluripotent Stem Cells into Functional β Islets Under 2D and 3D Culture Conditions and In Vivo Preclinical Validation of 3D Islets.
    Bose B; Sudheer PS
    Methods Mol Biol; 2016; 1341():257-84. PubMed ID: 25783769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro generation of human pluripotent stem cell derived lung organoids.
    Dye BR; Hill DR; Ferguson MA; Tsai YH; Nagy MS; Dyal R; Wells JM; Mayhew CN; Nattiv R; Klein OD; White ES; Deutsch GH; Spence JR
    Elife; 2015 Mar; 4():. PubMed ID: 25803487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypothalamic-pituitary organoid generation through the recapitulation of organogenesis.
    Ozaki H; Suga H; Arima H
    Dev Growth Differ; 2021 Feb; 63(2):154-165. PubMed ID: 33662152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manipulations of microRNA in human pluripotent stem cells and their derivatives.
    Rushing SN; Herren AW; Lieu DK; Li RA
    Methods Mol Biol; 2011; 690():107-20. PubMed ID: 21042988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothalamic Contribution to Pituitary Functions Is Recapitulated In Vitro Using 3D-Cultured Human iPS Cells.
    Kasai T; Suga H; Sakakibara M; Ozone C; Matsumoto R; Kano M; Mitsumoto K; Ogawa K; Kodani Y; Nagasaki H; Inoshita N; Sugiyama M; Onoue T; Tsunekawa T; Ito Y; Takagi H; Hagiwara D; Iwama S; Goto M; Banno R; Takahashi J; Arima H
    Cell Rep; 2020 Jan; 30(1):18-24.e5. PubMed ID: 31914385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specification of neuronal and glial subtypes from human pluripotent stem cells.
    Liu H; Zhang SC
    Cell Mol Life Sci; 2011 Dec; 68(24):3995-4008. PubMed ID: 21786144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Embryonic Stem Cell-Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic-Ischemic Mouse Brain.
    Hawkins KE; Corcelli M; Dowding K; Ranzoni AM; Vlahova F; Hau KL; Hunjan A; Peebles D; Gressens P; Hagberg H; de Coppi P; Hristova M; Guillot PV
    Stem Cells Transl Med; 2018 May; 7(5):439-449. PubMed ID: 29489062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of companion animal pluripotent stem cells.
    Paterson YZ; Kafarnik C; Guest DJ
    Cytometry A; 2018 Jan; 93(1):137-148. PubMed ID: 28678404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary cell differentiation from stem cells and other cells: toward restorative therapy for hypopituitarism?
    Willems C; Vankelecom H
    Regen Med; 2014; 9(4):513-34. PubMed ID: 25159067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. To clone or not to clone? Induced pluripotent stem cells can be generated in bulk culture.
    Willmann CA; Hemeda H; Pieper LA; Lenz M; Qin J; Joussen S; Sontag S; Wanek P; Denecke B; Schüler HM; Zenke M; Wagner W
    PLoS One; 2013; 8(5):e65324. PubMed ID: 23734247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs.
    Kim E; Hyun SH
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fabricating retinal pigment epithelial cell sheets derived from human induced pluripotent stem cells in an automated closed culture system for regenerative medicine.
    Matsumoto E; Koide N; Hanzawa H; Kiyama M; Ohta M; Kuwabara J; Takeda S; Takahashi M
    PLoS One; 2019; 14(3):e0212369. PubMed ID: 30865653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Veterinary applications of induced pluripotent stem cells: regenerative medicine and models for disease?
    Cebrian-Serrano A; Stout T; Dinnyes A
    Vet J; 2013 Oct; 198(1):34-42. PubMed ID: 24129109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pituitary stem cells: past, present and future perspectives.
    Pérez Millán MI; Cheung LYM; Mercogliano F; Camilletti MA; Chirino Felker GT; Moro LN; Miriuka S; Brinkmeier ML; Camper SA
    Nat Rev Endocrinol; 2024 Feb; 20(2):77-92. PubMed ID: 38102391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of human pluripotent stem cell therapeutics under defined xeno-free conditions: progress and challenges.
    Fan Y; Wu J; Ashok P; Hsiung M; Tzanakakis ES
    Stem Cell Rev Rep; 2015 Feb; 11(1):96-109. PubMed ID: 25077810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pluripotent Stem Cells for Cell Therapy.
    Schroeder IS
    Methods Mol Biol; 2021; 2269():25-33. PubMed ID: 33687669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.